HRT Financial’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,806
Closed -$152K 4087
2026
Q1
$152K Buy
+12,806
New +$131K ﹤0.01% 3262
2025
Q2
Sell
-407,482
Closed -$4.42M 2527
2025
Q1
$4.42M Buy
+407,482
New +$4.1M 0.03% 472
2024
Q2
Sell
-67,044
Closed -$771K 2148
2024
Q1
$771K Buy
+67,044
New +$569K ﹤0.01% 1016
2023
Q1
Sell
-22,709
Closed -$436K 2429
2022
Q4
$436K Sell
22,709
-130,397
-85% -$2.76M 0.01% 1515
2022
Q3
$2.88M Buy
153,106
+121,290
+381% +$2.49M 0.03% 484
2022
Q2
$573K Sell
31,816
-48,717
-60% -$791K 0.01% 1387
2022
Q1
$1.29M Buy
+80,533
New +$1.45M 0.01% 864
2021
Q4
Sell
-111,306
Closed -$2.59M 3102
2021
Q3
$2.59M Buy
+111,306
New +$2.69M 0.02% 575

Other funds holding AHCO

HRT Financial's AHCO Position: Q2 2026 in Review

HRT Financial sold out of AdaptHealth (AHCO) in Q2 2026, closing a stake of 12,806 shares — an estimated $152K sold.

HRT Financial first reported a position in AHCO in Q3 2021 and held it in 8 quarters. The position peaked at $4.42M in Q1 2025. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • HRT Financial reported no remaining AdaptHealth position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 12,806 AdaptHealth shares in Q2 2026, an estimated $152K.
  • HRT Financial first reported a position in AdaptHealth in Q3 2021 and held it in 8 quarters.
  • HRT Financial's AdaptHealth position peaked at $4.42M in Q1 2025.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.